B3GAT1 and neoplasm: This finding suggested that the trend of CD57+CD8+ T cells/ T cells ratio in tumor tissues was consistent with that in peripheral blood, indicating that the measurement of CD57+CD8+ T cells/T cells ratio in blood may be used as a predictive marker for ICI responders.